Skip to main content
logo
Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1624
-0.0046 (-2.75%)
At close: Mar 27, 2026

Immunovia AB Revenue

In the year 2025, Immunovia AB had annual revenue of 685.00K SEK, down -26.42%. Immunovia AB had revenue of 354.00K in the quarter ending December 31, 2025, a decrease of -22.20%.

Revenue
685.00K
Revenue Growth
-26.42%
P/S Ratio
159.48
Revenue / Employee
52.69K
Employees
13
Market Cap
109.24M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025685.00K-246.00K-26.42%
Dec 31, 2024931.00K-644.00K-40.89%
Dec 31, 20231.58M430.00K37.55%
Dec 31, 20221.15M301.00K35.66%
Dec 31, 2021844.00K482.00K133.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Getinge AB34.97B
Swedish Orphan Biovitrum AB28.24B
Medicover AB25.74B
Sectra AB3.52B
Arcoma AB130.80M
Iconovo AB14.53M
Biovica International AB10.93M
Alligator Bioscience AB4.42M
Revenue Rankings

Immunovia AB News

More News